undamentalytics Newsletter
Sign in

Dariohealth Corp. income statement

In fiscal 2025, Dariohealth Corp. reported revenue of $22.4m, down 17.3% on the year before, operating income of −$36.7m (a -163.9% margin) and net income of −$41.7m, or $10.12 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue00135788212820272221
Cost of revenue022—465517181414109
Gross profit0−3−1−112334106131312
Research and development54323444172020241410
General and administrative643355513241618201514
Operating income−14−11−8−11−14−18−18−30−76−57−56−58−37−32
Interest expense—————————2——35
Income before tax1413−7−11−16−18−18−29−77−62−59−45−42−35
Income tax————————000−200
Net income−14−13−7−11−16−18−18−29−77−62−59−43−42−36
Diluted EPS$304.00$148.00$307.20$8.36$6.56$156.30$8.00$80.20$4.07$2.54$1.93$12.27$10.12—
Diluted shares (average)—————————1m1m2m4m—
EBITDA−13−11−7−11−14−17−18−30−76−56−56−56−36−32

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: DRIO vs HCTIDRIO vs MNDRDRIO vs SOPH

More: Health Care Technology stocks compared, Health Care sector, rankings of US companies

Figures from Dariohealth Corp.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Dariohealth Corp.